# Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

> **NCT02819921** · PHASE4 · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 59 (actual)

## Conditions studied

- Hot Flashes
- Breast Neoplasms

## Interventions

- **DRUG:** Desvenlafaxine succinate 100mg
- **DRUG:** Desvenlafaxine succinate 50mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02819921
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-10
- **Primary completion:** 2019-03-15
- **Final completion:** 2019-06-15
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Difficulty in Recruiting Research Participants
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02819921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02819921, "Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02819921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*